Ayşe Balat

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

Robert L. Coleman, Amit M. Oza, Domenica Lorusso et al. · The Lancet · 2017 · 1.7K citations · Full text

Medicine, Gynecology, Oncology +12

Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial

I. Ray-Coquard, Alexandra Léary, Sandro Pignata et al. · Annals of Oncology · 2023 · 339 citations · Full text

Medicine, Oncology, Pharmacology +15

Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children

Agnes Trautmann, Sven Schnaidt, Beata S. Lipska‐Ziętkiewicz et al. · Journal of the American Society of Nephrology · 2017 · 222 citations · Full text

Medicine, Nephrology, Pediatrics +14

Disruption of PTPRO Causes Childhood-Onset Nephrotic Syndrome

Fatih Özaltın, Tulin Ibsirlioglu, Ekim Z. Taşkıran et al. · The American Journal of Human Genetics · 2011 · 117 citations · Full text

Medicine, Nephrology, Pathology +11

Childhood vasculitides in Turkey: a nationwide survey

Seza Özen, Ayşı̇n Bakkaloğlu, Ruhan Düşünsel et al. · Clinical Rheumatology · 2006 · 104 citations

Medicine, Child Health, Pediatrics +14